JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Serum NF-κB in Epstein-Barr Virus-Related Oropharyngeal Carcinoma Diagnostic Usability

  • 0Genomed S.A., 02-971 Warsaw, Poland.
Cancers +

|

July 13, 2024

|

July 13, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Nuclear factor kappa B (NF-κB) shows promise as a biomarker for Oropharyngeal Squamous Cell Carcinoma (OPSCC). Higher NF-κB levels correlate with EBV-positive OPSCC, advanced stages, and specific viral markers, aiding early diagnosis.

Area Of Science

  • Oncology
  • Biomarker Discovery
  • Molecular Biology

Background

  • Early cancer diagnosis and effective therapy remain critical challenges in oncology.
  • Nuclear factor kappa B (NF-κB) plays a significant role in both physiological and pathological processes.
  • Identifying reliable biomarkers is crucial for improving patient outcomes in Oropharyngeal Squamous Cell Carcinoma (OPSCC).

Purpose Of The Study

  • To evaluate the prevalence and serum levels of NF-κB in OPSCC patients.
  • To assess NF-κB levels in relation to tumor differentiation and TN classification.
  • To investigate correlations between NF-κB concentration and Epstein-Barr Virus (EBV) markers, viral load, and matrix metalloproteinases (MMPs).

Main Methods

  • Enzyme-Linked Immunosorbent Assay (ELISA) was used to quantify serum NF-κB levels.
  • Serum NF-κB levels were analyzed based on histological differentiation and TN staging.
  • Correlations were examined between NF-κB, EBV antibody titers, viral load, and MMP-3/MMP-9 concentrations.
  • Receiver Operating Characteristic (ROC) analysis was performed to confirm diagnostic accuracy.

Main Results

  • NF-κB levels were significantly elevated in EBV-related OPSCC compared to EBV-negative cases.
  • Higher NF-κB levels were observed in more advanced clinical stages of OPSCC.
  • A positive correlation was identified between NF-κB concentration and EBV antibody titers, viral load, and MMP-3/MMP-9 levels.

Conclusions

  • NF-κB is a promising biomarker for EBV-related OPSCC, particularly in advanced stages.
  • The correlation with EBV markers and MMPs suggests a role for NF-κB in disease progression.
  • NF-κB demonstrates diagnostic potential for OPSCC, warranting further investigation.

Keywords: